Effects of L-arginine therapy on nitric oxide production in patients with sickle cell disease.

被引:0
|
作者
Morris, C [1 ]
Kypers, F [1 ]
Larkin, S [1 ]
Kennedy, N [1 ]
Simon, J [1 ]
Vichinsky, E [1 ]
Styles, L [1 ]
机构
[1] Childrens Hosp Oakland, Oakland, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2858
引用
收藏
页码:695A / 695A
页数:1
相关论文
共 50 条
  • [1] L-arginine therapy paradoxically decreases nitric oxide production in patients with sickle cell disease
    Morris, CR
    Kuypers, F
    Larkin, S
    Kennedy, N
    Simon, J
    Vichinsky, E
    Styles, L
    PEDIATRIC RESEARCH, 1999, 45 (04) : 150A - 150A
  • [2] L-Arginine Therapy Paradoxically Decreases Nitric Oxide Production in Patients with Sickle Cell Disease
    Claudia R Morris
    Frans Kuypers
    Sandra Larkin
    Nancy Kennedy
    Julie Simon
    Elliott Vichinsky
    Lori Styles
    Pediatric Research, 1999, 45 : 150 - 150
  • [3] Hydroxyurea and arginine therapy: Impact on nitric oxide production in sickle cell disease.
    Morris, CR
    Vichinsky, EP
    van Warmerdam, J
    Machado, L
    Larkin, S
    Kuypers, FA
    BLOOD, 2001, 98 (11) : 785A - 785A
  • [4] Hydroxyurea and arginine therapy: Impact on nitric oxide production in sickle cell disease
    Morris, CR
    Vichinsky, EP
    van Warmerdam, J
    Machado, L
    Kepka-Lenhart, D
    Morris, SM
    Kuypers, FA
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (08) : 629 - 634
  • [5] Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytes
    Nahavandi, Masoud
    Tavakkoli, Fatemeh
    Millis, Richard M.
    Wyche, Melville Q.
    Habib, Muhammad J.
    Tavakoli, Nasrin
    HEMATOLOGY, 2006, 11 (04) : 291 - 294
  • [6] Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease
    Morris, CR
    Kuypers, FA
    Larkin, S
    Sweeters, N
    Simon, J
    Vichinsky, EP
    Styles, LA
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (02) : 498 - 500
  • [7] Is L-arginine, the substrate for nitric oxide, altered in adult vasoocclusive sickle cell crisis?
    Lopez, BL
    Kreshak, AA
    Morris, CR
    Ballas, SK
    Davis-Moon, L
    Ma, XL
    BLOOD, 2002, 100 (11) : 452A - 452A
  • [8] Nitric oxide metabolites are reduced in patients with sickle cell disease.
    ThornleyBrown, D
    Freeman, BA
    Chumley, P
    Lowenthal, EA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1624 - A1624
  • [9] Decreased exhaled nitric oxide (NO) in patients with sickle cell disease.
    Qureshi, MA
    Gugnani, MK
    Swerdlow, PS
    Girgis, RE
    BLOOD, 2000, 96 (11) : 599A - +
  • [10] Correlation of nitric oxide (center dot NO) metabolites with plasma L-arginine in adults with sickle cell disease (SCD).
    Lowenthal, E
    ThornleyBrown, D
    Rutledge, I
    Patton, J
    Chumley, P
    Redden, D
    Freeman, BA
    BLOOD, 1996, 88 (10) : 35 - 35